Dr Reddys commissions mPEG alcohol manufacturing facility

Published: 17-Mar-2010
Manufacturing

Dedicated facility will operate to c-GMP standards

The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories has successfully commissioned a commercial scale manufacturing facility for pharma grade mPEG alcohols at its Cuernavaca facility in Mexico. It represents a significant investment in a dedicated facility operated to c-GMP standards.

The new facility is capable of producing a wide range of molecular weight mPEGs and has a multitonne annual capacity. The mPEG alcohol manufactured in Mexico will be supplied to Dr. Reddy’s c-GMP facility in Mirfield, UK, where commercial scale activation is carried out.

mPEG alcohols are the key raw materials for Activated mPEG, extensively used for pegylation with biologic drugs and increasingly for peptides and small molecule pharmaceuticals. Dr. Reddy’s has officially branded its extensive range of Activated mPEGs under the name PEGtech.

PEGtech branding has been used to bring together a broad product range comprising a variety of activating groups and molecular weights (5-60 kDa), which are now fully supported by backward integration to the key starting materials. It furthermore highlights the company’s extensive experience in product development and GMP manufacture of the Activated mPEGs.

‘Our investment in the world class mPEG alcohol facility in Mexico underlines our commitment to the growing market for Activated mPEGs,’ said Satish Reddy, managing director and coo, Dr. Reddy’s, ‘By introducing the PEGtech brand, our customers can be assured of the same high quality standards and customer service as they develop their PEGylated biologic drugs or small molecules from the laboratory right through to commercial applications.’
See more

You may also like

Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part III)

Read more
The third instalment from the CPHI Frankfurt show floor explores practical approaches and fresh perspectives on scale-up, tech transfer, and manufacturing innovation across the pharmaceutical sector

Trending Articles

  1. Touchlight named most innovative new manufacturing facility at ISPE 2025 Facility of the Year Awards The company’s restored Victorian waterworks site in Hampton, London, has been recognised for transforming DNA manufacturing with its enzymatic, cell-free dbDNA platform
  2. Aseptic spray drying: Transforming biotherapeutics for a new era With interest in aseptic spray drying on the rise in the pharmaceutical industry, Dr Kevin Robinson spoke to GEA’s David Costes about how the company is combining process, engineering and technological expertise with market insights to provide a safe, reliable and high-performance technology for advanced biotherapeutic powder applications
  3. ACG to invest $200m in US hard-shell capsule manufacturing ACG will build its first US capsule manufacturing facility in Atlanta, Georgia, with dedicated gelatine and HPMC lines, creating more than 200 jobs and expanding its North American presence ahead of operations starting in early 2027
  4. Roquette opens pharmaceutical innovation centre in Brazil The Health & Pharma Solutions facility in São Paolo offers state-of-the-art laboratories for customers, with the Northeast Center for Strategic Technologies partnering with Roquette to empower young women to pursue careers in science through the Futuras Cientistas programme at the facility
  5. Pharma Partnering US Summit 20225 is all set to commence in Boston on 13–14 November 2025 This high-impact conference brings together top executives from pharma, biotech, investment firms, and advisory groups for two dynamic days of deal-making, networking, and thought leadership

You may also like

Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part III)

The third instalment from the CPHI Frankfurt show floor explores practical approaches and fresh perspectives on scale-up, tech transfer, and manufacturing innovation across the pharmaceutical sector
Manufacturing

Streamlining bioconjugation for next-generation ADC development

Abzena’s proprietary ThioBridge™ technology delivers precision, scalability, and enhanced stability for antibody-drug conjugates
Manufacturing

OPTIMA machinery USA Corporation marks 40 years of growth and innovation in the US

OPTIMA machinery USA Corporation, a subsidiary of the German-based OPTIMA Packaging Group, is celebrating 40 years of successful operations in the United States
Manufacturing

How to execute a successful remediation strategy

NSF’s experts share guidance on building sustainable compliance and avoiding quick fixes
Manufacturing

How to optimise your quality culture and maturity for success

NSF outlines how aligning culture, leadership and systems can strengthen compliance and performance
Manufacturing

Frontline innovation: dispatches from the show floor at CPHI Frankfurt (part II)

Industry leaders at CPHI Frankfurt are embracing emerging technologies — including automation, AI, advanced analytics and innovative manufacturing platforms — to drive efficiency, quality, scalability and sustainability in pharmaceutical production and development
Manufacturing

Five trends on Solvias’ radar at CPHI Frankfurt 2025

The Solvias team shares its perspective on the scientific and regulatory shifts expected to be front and centre at this year’s event
Subscribe now